Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marika Lappalainen"'
Autor:
Marika Lappalainen, Anna Kaisa Purhonen, Matti Vänskä, Sini Korpelainen, Sari Hämäläinen, Esa Jantunen, Carina Intke, Kari Pulkki, Auni Juutilainen
Publikováno v:
Clinical and experimental medicine. 22(1)
The study aim was to determine the benefit of the measurement of serum caspase-cleaved cytokeratin-18 (CK-18) fragment as a prognostic marker of febrile neutropenia (FN) in hematological patients. The study population consisted of 86 consecutive pati
Autor:
Marja Pyörälä, Auni Juutilainen, Sari Hämäläinen, Kari Pulkki, Esa Jantunen, Irma Koivula, Marika Lappalainen, Tuomo Romppanen
Publikováno v:
European journal of haematologyREFERENCES. 105(6)
Objectives To evaluate quick Sequential Organ Failure Assessment (qSOFA) score during febrile neutropenia (FN) in adult patients receiving intensive chemotherapy for acute myeloid leukemia (AML). Methods qSOFA score, as well as the association of qSO
Autor:
Sari Hämäläinen, Miika Arvonen, Kari Pulkki, Esa Jantunen, Stefan Becker, Auni Juutilainen, Marika Lappalainen, Pekka Riikonen, Sini Korpelainen
Publikováno v:
Leukemialymphoma. 60(12)
Commonly used indicators of sepsis are nonspecific and insufficient for predicting the course of febrile neutropenia (FN) in hematological patients. We analyzed data from 91 adult FN patients who received intensive chemotherapy for acute myeloid leuk
Autor:
Jenna Jokkala, Kari Pulkki, Sari Hämäläinen, Esa Jantunen, Marika Lappalainen, Kati Hanhineva, Auni Juutilainen, Irma Koivula
Publikováno v:
Disease Markers, Vol 2018 (2018)
Disease Markers
Disease Markers
Background. Novel potential small molecular biomarkers for sepsis were analyzed with nontargeted metabolite profiling to find biomarkers for febrile neutropenia after intensive chemotherapy for hematological malignancies. Methods. Altogether, 85 pati
Autor:
Auni Juutilainen, Esa Jantunen, Kari Pulkki, Irma Koivula, Sari Hämäläinen, Marika Lappalainen
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 77(2)
Asymmetric dimethylarginine (ADMA) has been recognized as an independent prognostic factor for sepsis mortality in intensive care units. No data are available on kinetics or prognostic value of ADMA in hematological patients. We evaluated the ability